Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
Joseph J Palamar, Mark K Su, Robert S Hoffman
The American Journal of Drug and Alcohol Abuse December 17, 2015 DOI: 10.3109/00952990.2015.1106551 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study of poison control center data Peer reviewed |
|---|---|
| Population | Individuals with drug-related exposures reported to poison control centers in the five counties of New York City and Long Island, 2011-2014 |
| Duration | 2011-2014 |
| Topics | MDMA |
| Keywords | Humans Poisoning Psychotropic drugs Prevalence Risk factors Adolescent Poison control centers New york city Female Young adult Cannabinoid receptor agonists Drug exposures Novel psychoactive substances Synthetic cathinones 4-methylenedioxy-methamphetamine Ecstasy 3 |
| Key findings | NPS exposures increased from 7.1% to 12.6% of drug-related exposures between 2011 and 2014, with 82.3% involving SCRAs. NPS users were more likely to be younger, male, and to have not co-used other drugs than other drug-exposure cases. SCRA exposures rose sharply in 2014, and the mean age of SCRA users increased over time. |
Abstract
Background: Novel psychoactive substances (NPS) are emerging at an unprecedented rate. Likewise, prevalence of use and poisonings has increased in recent years.
Objective: To compare characteristics of NPS exposures and non-NPS-drug-related exposures and to examine whether there are differences between exposures involving synthetic cannabinoid receptor agonists (SCRAs) and other NPS.
Methods: Poison control center data from the five counties of New York City and Long Island were examined from 2011-2014. We examined prevalence and characteristics of NPS exposures (classified as intentional abuse) and compared characteristics of cases involving SCRAs and other NPS.
Results: Prevalence of NPS exposures was 7.1% in 2011, rising to 12.6% in 2014. Most exposures (82.3%) involved SCRA use. The second and third most prevalent classes were phenethylamines/synthetic cathinones ("bath salts"; 10.2%) and psychedelic phenethylamines (4.3%). Compared to other drug-related exposures (i.e. involving licit and illicit drugs), those who used NPS were more likely to be younger, male, and to have not co-used other drugs (ps < 0.001). SCRA exposures increased sharply in 2014 and the mean age of users increased over time (p < 0.01). Females exposed to SCRAs were younger than males (p < 0.001), and in 2014, individuals exposed to SCRAs were more likely to report concomitant use of alcohol than users of other NPS (p = 0.010). Users of other NPS were more likely than SCRA users to report concomitant use of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)/"Molly" (p < 0.001).
Conclusion: Exposures reported to the poison center that involve NPS are increasing and the majority involve SCRAs. These findings should inform prevention and harm reduction approaches.
Comparable studies
Other observational and cohort studies on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Subjective Reports of the Effects of MDMA in a Clinical Setting Individuals who took MDMA in a clinical setting | 1986 | Observational study | |
| Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users | 1998 | Observational cohort | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| The Psychological and Physiological Effects of MDMA on Normal Volunteers Older, more educated, drug-experienced individuals | 1986 | Observational cohort | |
| Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits Young people who were regular or novice MDMA users, or non-users | 1998 | Observational cohort | n = 30 |
Citations in the library
Cited by 9
- Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. The American Journal of Drug and Alcohol Abuse November 1, 2016
- Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States. American Journal on Addictions August 1, 2016
- The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides. Psychopharmacology June 1, 2022
- Triggers of highly lethal seizures induced by novel stimulants: A systematic review focused on synthetic cathinones and phenethylamines. Neurotoxicology January 14, 2026
- Characteristics of poisonings involving ketamine in the United States, 2019-2021. Journal of Psychopharmacology August 2023
and 4 more in the library
Cites 5
- Novel psychoactive substances of interest for psychiatry World Psychiatry February 1, 2016
- Mind navigators of chemicals' experimenters? A web-based description of e-psychonauts. Cyberpsychology, behavior and social networking May 1, 2015
- Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project Scandinavian Journal of Clinical and Laboratory Investigation May 22, 2013
- Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence September 3, 2015
- A web-based survey on mephedrone. Drug and Alcohol Dependence October 1, 2011